Elanco Animal Health Incorporated ELAN
Super Investor & Insider
2
Fondi che lo detengono
#404
Rank consenso
2.9%
% dei portafogli
$1.65B
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Dodge & Cox · Dodge & Cox | 0.91% | Reduce 12.82% | 68,944,100 | $1.65B |
| Lee Ainslie · Maverick Capital | 0.04% | Add 35.52% | 144,457 | $3.5M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to prevent and treat diseases in both companion animals and livestock, including dogs, cats, cattle, poultry, swine, sheep…
SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees9,400
TickerELAN
Statistics
Market Cap$11.81B
Revenue (TTM)$4.71B
Net Income-$232.0M
Net Margin-4.9%
EPS$-0.47
P/E377.14
P/S2.45
P/B1.85
EV/EBITDA15.77
ROE-3.8%
Dividend Yield—
Price$23.64
Data: Twelve Data · Revenue = mcap / P/S